Interventional Neuromodulation in Fibromyalgia

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

September 1, 2023

Study Completion Date

April 15, 2024

Conditions
Neuromodulation and Sleep Disorders
Interventions
DEVICE

repetitive transcranial magnetic stimulation active stimulation

This study was conducted on 20 eligible fibromyalgia patients with sleep disorders. They were randomized to have 20 sessions of active rTMS (1 Hz, 120% of resting motor threshold with total 1200 pules /session) over the right dorsolateral prefrontal area (DLPFC) for 5 sessions/week for 4 weeks.

DEVICE

repetitive transcranial magnetic stimulation sham stimulation

This study was conducted on 20 eligible fibromyalgia patients with sleep disorders. They were randomized to have 20 sessions of sham rTMS (1 Hz, 120% of resting motor threshold with total 1200 pules /session) over the right dorsolateral prefrontal area (DLPFC) for 5 sessions/week for 4 weeks.

Trial Locations (1)

6620010

RECRUITING

Faculty of medicine, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06373445 - Interventional Neuromodulation in Fibromyalgia | Biotech Hunter | Biotech Hunter